Chandler Robinson
Director, Chief Executive Officer · 3 filings · Latest: Jun 30, 2026
Monopar Therapeutics
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MNPR | Chandler Robinson | Director, Chief Executive Officer | Jun 30, 2026 | Option Exercise | — | 12,873 | — | 103,351 | |
MNPR | Chandler Robinson | Director, Chief Executive Officer | Mar 31, 2026 | Option Exercise | — | 6,732 | — | 92,450 | |
MNPR | Robinson Chandler | — | Jul 14, 2025 | Proposed Sale | $40.00 | 16,800 | $672.0K | — |